SEMINAR AGENDA AND PARTICIPANTS

1)A planning Meeting for “US-Japan Cooperative Pathology Study of Radiation Related Breast Cancer”
Nashville, Tennessee, July 16-20, 1979

AGENDA
I. Seminar
July 16-18, 1979

1. Review of Previous Study on Breast Cancer Related to Radiation in both Japan and United States Dr. S. Tokuoka
Dr. D. E. Henson
2. Review of Previous Study on Breast Cancer in Atomic Bomb Survivors Dr. M. Tokunaga
3. Plan of Present Study
a. Case Material to be Included Dr. D. E. Henson
Dr. M. Tokunaga
b. Collection of Material Dr. M. Asano
Dr. T. Yamamoto
c. Classification of Breast Cancer
1) New WHO Classification Dr. W. H. Hartmann
2) Classification of Japan Mammary Cancer Dr. G. Sakamoto Society (JMCS)
3) Classification to be Applied Dr. R. V. P. Hutter
d. Protocol Design Dr. D. E. Henson
Dr. M. Tokunaga
e. Format and Time of Present Study Dr. D. E. Henson
f. Analysis of Data and Final Report Dr. S. Tokuoka
4. General Discussion
5. Conclusion

II. Workshop of Histological Classification
July 19-20, 1979
Each of the bi-national participants worked on histological tissue slides of 20 breast cancer cases that were prepared by the U.S. side, to classify each tumor. Following the microscopic work, all cases were reviewed and discussed by all until they came to agree on one conclusive classification on each case.


PARTICIPANTS

United States
Donald E. Henson, M.D. Investigator Laboratory of Pathology National Cancer Institute NIH, Bethesda, Md.
William H. Hartmann, M.D. Professor Department of Pathology Vanderbilt University Nashville, Tenn.
Robert V. P. Hutter, M.D. Chief Department of Pathology St. Barnabas Hospital Newark, N. J.

Japan
Shoji Tokuoka, M.D. Professor Department of Pathology Hiroshima University School of Medicine Hiroshima 730
Goi Sakamoto, M.D. Associate Member Department of Pathology Cancer Institute Tokyo 170
Masahide Asano, M.D. Vice Chief Department of Pathology RERF Nagasaki 850
Tsutomu Yamamoto, M.D. Vice Chief Department of Pathology RERF Hiroshima 730
Masayoshi Tokunaga, M.D. Instructor Department of Pathology Kagoshima University School of Medicine Kagoshima 890



2) Pathological Review Meeting on Radiation Related Breast Cancer
Nagasaki and Hiroshima, November 26-December 4, 1979

AGENDA
I. Seminar
Pathological Review at Radiation Effect Research Foundation (RERF) at Nagasaki
November 26-November 28, 1979
Pathological Review at RERF at Hiroshima
November 29-December 2, 1979
Summation meeting at RERF in Hiroshima
December 3-December 4, 1979
Session 1 Histological diagnosis of 302 cases of breast cancer in exposed and non-exposed females Dr. S. Tokuoka
Dr. D. E. Henson
Dr. M. Tokunaga
Session 2 Histological classification adopted by this study group Dr. W. H. Hartmann
Dr. Goi Sakamoto
Session 3 Publication of results Dr. S. Tokuoka
Dr. D. E. Henson
Session 4 The findings and significance of histological changes of the breast tissue in “Pilot Study” Dr. R. V. P. Hutter
Dr. M. Asano
Dr. T. Yamamoto
Session 5 Radiation related breast cancerRadiation related breast cancer cases in the U.S.A. Dr. D. E. Henson

PARTICIPANTS

United States
Donald E. Henson, M.D. Investigator Laboratory of Pathology National Cancer Institute NIH, Bethesda, Md.
William H. Hartmann, M.D. Professor Department of Pathology Vanderbilt University Nashville, Tenn.
Robert V. P. Hutter, M.D. Chief Department of Pathology St. Barnabas Hospital Newark, N.J.
William J. Schull, Ph.D. Acting Director and Head Department of Epidemiology RERF Hiroshima 730
Robert W. Miller, M.D. Chief Clinical Epidemiology Bran National Cancer Institute NIH, Bethesda, Md.

Japan
Shoji Tokuoka, M.D. Professor Department of Pathology Hiroshima University School of Medicine Hiroshima 730
Goi Sakamoto, M.D. Associate Member Department of Pathology Cancer Institute Tokyo 170
Masayoshi Tokunaga, M.D. Instructor Department of Pathology Kagoshima University School of Medicine Kagoshima 890
Masahide Asano, M.D. Vice Chief Department of Pathology RERF Nagasaki 850
Tsutomu Yamamoto, M.D. Vice Chief Department of Pathology RERF Hiroshima 730
Toshio Fujikura, M.D. Chief Department of Pathology RE RF Hiroshima 730
Hiroo Kato, M.D. Vice Chief Department of Epidemiology RE RF Hiroshima 730
Haruo Sugano, M.D. Director Cancer Institute Tokyo 170